Originally published In Press as doi:10.1074/jbc.M111101200 on March 4, 2002
J. Biol. Chem., Vol. 277, Issue 20, 17597-17604, May 17, 2002
Dynamin Is a Minibrain Kinase/Dual Specificity
Yak1-related Kinase 1A Substrate*
Mo-Chou
Chen-Hwang
,
Huey-Ru
Chen§¶,
Marshall
Elzinga
, and
Yu-Wen
Hwang
§**
From the
Molecular Biology Department, New York State
Institute for Basic Research in Developmental Disabilities, Staten
Island, New York 10314, § Department of Life Science,
National Yang-Ming University, Pei-Tou, Taipei 112, Taiwan, and
** CSI/IBR Center for Developmental
Neuroscience and Graduate Program in Biology, City University of New
York, New York, New York 10016
Received for publication, November 20, 2001, and in revised form, February 28, 2002
 |
ABSTRACT |
The minibrain kinase
(Mnbk)/dual specificity Yak 1-related kinase 1A
(Dyrk1A) gene is implicated in the mental retardation associated with Down's syndrome. It encodes a proline-directed serine/threonine kinase whose function has yet to be defined. We have
used a solid-phase Mnbk/Dyrk1A kinase assay to aid in the search for
the cellular Mnbk/Dyrk1A substrates. The assay revealed that rat brain
contains two cytosolic proteins, one with a molecular mass of
100 kDa and one with a molecular mass of 140 kDa, that were prominently
phosphorylated by Mnbk/Dyrk1A. The 100-kDa protein was purified and
identified as dynamin 1. The conclusion was further supported by
evidence that a recombinant glutathione S-transferase
fusion protein containing dynamin isoform 1aa was phosphorylated by
Mnbk/Dyrk1A. In addition to isoform 1aa, Mnbk/Dyrk1A also
phosphorylated isoforms 1ab and 2aa but not human MxA protein when
analyzed by the solid-phase kinase assay. Upon Mnbk/Dyrk1A
phosphorylation, the interaction of dynamin 1 with the Src homology 3 domain of amphiphysin 1 was reduced. However, when Mnbk/Dyrk1A
phosphorylation was allowed to proceed more extensively, the
phosphorylation enhanced rather than reduced the binding of dynamin 1 to amphiphysin 1. The result suggests that Mnbk/Dyrk1A can play a dual
role in regulating the interaction of dynamin 1 with amphiphysin 1. Mnbk/Dyrk1A phosphorylation also reduced the interaction of dynamin
with endophilin 1, whereas the same phosphorylation enhanced the
binding of dynamin 1 to Grb2. Nevertheless, the dual function of
Mnbk/Dyrk1A phosphorylation was not observed for the interaction of
dynamin 1 with endophilin 1 or Grb2. The interactions of dynamin
with amphiphysin and endophilin are essential for the formation of
endocytic complexes; our results suggest that Mnbk/Dyrk1A may function
as a regulator controlling the assembly of endocytic apparatus.
 |
INTRODUCTION |
Minibrain kinase
(Mnbk)1 was
originally identified in Drosophila as a mutation affecting
neurogenesis (1). Mnbk mutant flies, which have low levels
of kinase expression, possess fewer neuroblasts and a reduced brain
volume as compared with the wild type (WT), especially in the optic
lobes and central brain (1). The reduction in brain size leads to
several distinct learning and behavioral defects. Because the
Mnbk mutation does not appear to affect the development of
Drosophila until late in the third instar, it was postulated
that the Mnbk gene is required for the proliferation of
neuroblasts during postembryonic neurogenesis (1).
Dual specificity Yak 1-related kinase (Dyrk) 1A was subsequently cloned
(2-5) and identified as the mammalian homologue of the
Drosophila Mnbk gene. The
Mnbk/Dyrk1A gene is a member of a growing
family of Dyrk-related genes (6) whose members include Yak1
(7), several Dyrks (8), ANPK (9), HIPK2 (10), Mirk (11), Myak (12), and
Pom1p (13). Mammalian Mnbk/Dyrk1A gene contains either 763 or 754 amino acid residues as a result of alternative splicing (2). The
kinase domain of Mnbk/Dyrk1A, consisting of ~320 residues, is located
roughly in the center of the protein. In addition to the 11 subdomains
characteristic of all protein kinases (14), the Mnbk/Dyrk1A kinase
domain contains several signature motifs unique to the Dyrk family.
These motifs include the sequence DFGSSC in subdomain VII, a
substitution of a highly conserved arginine in subdomain VIB by
cysteine, and a YXY motif between subdomains VII and VIII
(6). Outside the kinase domain, Mnbk/Dyrk1A contains a bipartite
nuclear target sequence (15), a PEST (proline, glutamate, serine, and
threonine) region, a 13-residue histidine repeat, and a
serine/threonine repeat near the C-terminal end. Little is known about
the functions of these structural features except for the bipartite
nuclear targeting sequence. The targeting sequence has been shown to
guide overexpressed Mnbk/Dyrk1A into the nucleus (8, 16).
Several lines of evidence suggest that the Mnbk/Dyrk1A gene
plays a role in causing the mental retardation phenotype of Down's syndrome. The human Mnbk/Dyrk1A gene maps
to the q22.2 region of chromosome 21 (4, 17-20), a section of
chromosome 21 known to associate with the mental retardation phenotype
of Down's syndrome (21). Mnbk/Dyrk1A is highly expressed in the
cortex, spinal cord, and olfactory bulb in developing mouse embryos.
The patterns of Mnbk/Dyrk1A expression appear to correlate well with
the regions of brain affected the most by Down's syndrome (3, 22).
Significantly, when transgenic mice carry additional
Mnbk/Dyrk1A genes, a situation mimicking
Down's syndrome, the animals exhibit various learning and memory
defects (23, 24).
Mnbk/Dyrk1A was originally proposed to be a dual specificity protein
kinase (2). However, the dual specificity appears to be limited only to
Mnbk/Dyrk1A autophosphorylation because the kinase is unable to
phosphorylate tyrosine residues on exogenous substrates (8). By using
histone and synthetic peptides as the target for phosphorylation,
Mnbk/Dyrk1A was subsequently determined to be a proline-directed
serine/threonine kinase, and the preferred phosphorylation site was
identified as RPX(S/T)P (25). Several potential
Mnbk/Dyrk1A substrates were recently identified. These substrates
include eukaryotic initiation factor 2B
, the microtubule-associated protein tau, transcription factor forkhead in rhabdomyosarcoma, and the cAMP-response element-binding protein (26-28). Despite this
progress, the roles of the Mnbk/Dyrk1A gene
in cellular processes are far from established. To unveil its
functions, we have conducted a generalized search for the kinase's
substrates in rat brain. We show here that one of the major substrates
in rat brain is dynamin 1 and that Mnbk/Dyrk1A phosphorylation
modulates the interaction of dynamin with SH3 domain-containing proteins.
 |
MATERIALS AND METHODS |
Clone Construction--
The full-length
Mnbk/Dyrk1A gene was obtained by PCR from
rat testis Quick-clone cDNA (CLONTECH) by using
the following sequence-specific oligonucleotides,
tctcatcgatgcatacaggaggagagacttcagcatgc and
ctctctcgagtcacgagctagctacaggactctgttgcac, respectively, as the 5' and
3' primers for amplification. PCR produced a 2.3-kb amplicon, as
expected for the full-length rat Mnbk/Dyrk1A gene. The PCR product was then
digested with ClaI and XhoI (both restriction
sites were introduced by the PCR primers) and cloned into restriction
site-modified glutathione S-transferase (GST) fusion vector
pGEX-3X, as described previously (29). The coding region of the cloned
Mnbk/Dyrk1A gene was sequenced. We found
two mismatches between our clone and the published sequence (2); both
of them are silent. The sequencing also disclosed that our clone
encodes the 754-residue isoform (2). A similar approach was used to
construct GST fusion proteins containing the SH3 domain of human
amphiphysin 1 (residues 545-696) (30) and the full-length human
endophilin 1 (31, 32). The primer pair
cctatcgatggccgacatcaagacgggcatcttcgc and
cctctcgagctaatctaagcgtcgggtgaagttctc was used for amplifying
amphiphysin 1, whereas the primer pair cctatcgatgtcggtggccggcctcaagaagcag and
ggactcgagctaatggggcagggcaaccagaatttc was used for generating endophilin
1. GST-dynamin 1aa (rat), GST-dynamin 2aa (rat), and GST-MxA (human)
clones were constructed from pCMV96-7 (33), pCMV96-7 (33), and p78/2-8b
(34), respectively, by PCR and subcloning. Kinase-deficient
GST-Mnbk/Dyrk1A harboring Y319F and Y321F double mutation (DF) was
constructed by site-directed mutagenesis by using oligonucleotide
gcgactctgaataaactggaatattctctgccccaa as the primer. The primer
simultaneously converts both tyrosines to phenylalanines in a single step.
Preparation of the GST Fusion Proteins--
GST fusion proteins
were expressed in Escherichia coli as described previously
(29). We found that GST-Mnbk/Dyrk1A purified by nickel-nitrilotriacetic
acid resin (which binds to the 13-histidine repeat of Mnbk/Dyrk1A)
tends to have a higher specific activity than that prepared by
glutathione resin; therefore, GST-Mnbk/Dyrk1A was routinely purified by
using nickel-nitrilotriacetic acid resin as suggested by the
manufacturer. All other GST fusion proteins were purified by using
glutathione-Sepharose 4B as described previously (29). Protein
concentration was determined by the Bradford method (35) with bovine
serum albumin used as a standard.
Kinase Assays--
The solid-phase kinase assay (denatured
assay) was performed as follows. Proteins to be tested were separated
by SDS-PAGE (minigel) and then transferred onto Immobilon-P membranes
(Millipore, Bedford, MA). After the transfer, membranes were blocked by
shaking them in 20 ml of blocking buffer (25 mM HEPES, pH
7.5, 100 mM NaCl, 1.5% bovine serum albumin, and 0.05%
sodium azide) at room temperature for 60 min. The blocked membrane was
then washed once with 20 ml of 25 mM HEPES, pH 7.5, for 10 min at room temperature before subjecting it to kinase reaction. The
reaction was performed by incubating the membrane with shaking in 3.5 ml of kinase buffer (25 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM MgCl2, and 5 mM MnCl2) containing 5 µM cold
ATP, 40 µCi of [
-32P]ATP (specific activity, 7000 Ci/mmol), and 10 µg of GST-Mnbk/Dyrk1A at room temperature for 60 min. The membranes were then washed as described by Ferrell and Martin
(36) to reduce the background. Phosphorylated bands were detected by
autoradiography. The solution kinase assay (native assay) was performed
in a 30-µl reaction mixture containing kinase buffer, 1 µg of
Sub-100 (dynamin 1), 5 µM ATP, and 2 µCi of
[
-32P]ATP (7000 Ci/mmol) if needed. The reaction was
initiated by the addition of GST-Mnbk/Dyrk1A and allowed to proceed at
30 °C. To determine the time course of phosphate incorporation, a
5-µl aliquot of reaction mixture was withdrawn at the indicated
times, precipitated together with 100 µg of bovine serum albumin in 2 ml of silicotungstic acid (4% in 3 N sulfuric acid),
collected onto a glass fiber filter (Whatman GF/B), and quantified by a scintillation counter. To determine the kinetic parameters of phosphorylation, Sub-100 (0.5-5 µg) was phosphorylated with 0.05 µg of GST-Mnbk/Dyrk1A for 10 min at 30 °C and quantified as
described in the solution kinase assay. After correcting for the
backgrounds (substrate and enzyme alone), the rate of phosphate
incorporation was then used to fit the Michaelis-Menten equation to
determine Vmax and Km for the
phosphorylation reaction. The kcat was then
calculated as Vmax/[Mnbk/Dyrk1A]. The data
presented were the average of three independent assays.
Purification of Sub-100--
Sub-100 was purified from rat brain
aqueous extracts as follows. All procedures were performed at either
0 °C or 4 °C unless stated otherwise. Adult rat brains
(unstripped) were obtained from PelFreez Biological (Rogers, AK) and
homogenized in homogenization buffer (3.5 ml/brain) containing 25 mM Tris-HCl, pH 7.4, 25 mM NaCl, 2 mM EDTA, 1 mM DTT, and 0.5 mM
phenylmethylsulfonyl fluoride by using a glass Dounce homogenizer. This
buffer released at least 50% of total cellular Sub-100. Brain lysate
was obtained by centrifugation at 30,000 × g for 20 min, followed by a second centrifugation at 100,000 × g for 60 min. The recovered supernatant was dialyzed overnight against Tris-buffer A (25 mM Tris-HCl, pH 7.4, and 25 mM NaCl) plus 1 mM DTT and 0.5 mM phenylmethylsulfonyl fluoride. After removing
precipitates by centrifugation (12,000 × g for 20 min), the brain lysate was loaded onto a Mono Q (HR 10/10) column
(Amersham Biosciences) attached to a fast protein liquid chromatography. The column was then eluted with a 0-0.4
M NaCl gradient (0.02 M NaCl gradient/min in
Tris-Buffer A and 1 mM DTT; flow rate, 3 ml/min) at room
temperature, and 20 one-minute fractions were collected. Each fraction
was analyzed for the presence of Sub-100 by the solid-phase kinase
assay. Sub-100 was eluted from Mono Q column with 0.16-0.22
M NaCl. Sub-100 fractions were pooled and mixed with an
equal volume of 3.2 M
(NH4)2SO4 (at 0 °C), which quantitatively precipitates Sub-100. The precipitates were collected by
centrifugation (12,000 × g for 10 min), dissolved in 3 ml of Tris-buffer A, and dialyzed overnight against 1000 ml of buffer containing 25 mM MES (pH 6.5), 25 mM NaCl, and
1 mM DTT. Sub-100 precipitated during dialysis. The
precipitates were then collected by centrifugation and extracted three
times with 100 µl of Tris-buffer A. This extraction recovered about
70% of the precipitated Sub-100 in solution. A final concentration of
100 mM NaCl was then added to Sub-100 solution to stabilize
the protein. The proteins were stored at
70 °C until use.
Purification of Sub-140 has been achieved recently and will be
described elsewhere. Brain SDS extract was prepared by homogenizing rat
brains in homogenization buffer containing 1% SDS followed by
centrifugation at 30,000 × g for 20 min.
Protein Sequencing--
Sub-100 to be sequenced was further
purified on an 8% Tricine SDS-PAGE gel and transferred onto an
Immobilon-CD membrane (Millipore). The area of membrane containing
Sub-100 was cut into small strips and placed into a 1.5-ml screw-cap
microcentrifuge tube. Enough cyanogen bromide solution (20 mg/ml in
70% formic acid) to cover membrane strips was added to the tube,
followed by incubation at room temperature under nitrogen and in the
dark for 16 h. Digested peptides were recovered in formic acid,
dried under vacuum, and then resolved on a 12% Tricine SDS-PAGE gel.
Separated peptides were then transferred to an Immobilon-P membrane,
stained with Coomassie Blue, and sequenced as membrane-bound material
by using an Applied Biosystems automatic sequencer.
Protein-Protein Binding Assays--
Binding of dynamin to SH3
domain-containing proteins was performed as follows. Dynamin (1 µg)
was first phosphorylated by 0.05-0.8 µg of GST-Mnbk/Dyrk1A in
solution for 30 min at 30 °C, but no radioactive ATP was included in
the reaction. The phosphorylated dynamin was then diluted with binding
buffer (25 mM Tris, pH 7.4, 50 mM NaCl, 5 mM EDTA, and 1 mM DTT) to 200 µl and mixed
with a 50-µl suspension of glutathione resin precoated with GST or GST fusion protein for 16 h at 4 °C. The resin was collected by centrifugation and washed five times by tumbling in the washing buffer
(25 mM Tris, pH 7.4, 150 mM NaCl, and 1%
Triton X-100) for 5 min at room temperature. Following the washings,
the resin-bound proteins were eluted with 60 µl of buffer containing
100 mM Tris, pH 8.0, and 20 mM glutathione and
subjected to Western blotting analysis. The blot was probed with mouse
monoclonal anti-dynamin antibody Hudy-1 (37) (Upstate Biotechnology,
Lake Placid, NY) (1:5000 dilution) and visualized by using sheep
anti-mouse alkaline phosphatase-conjugated secondary antibody (Sigma)
(1:5000 dilution) and CDP-Star chemiluminescence reagent (Applied
Biosystems/Tropix, Foster City, CA). The quantitation of dynamin was
performed by scanning x-ray films and analyzing the scanned images with
the National Institutes of Health Image program. Precoating of
glutathione resin with GST or GST fusion protein was prepared by
incubation with tumbling of 200 µl (bed volume) of washed (twice with
washing buffer) glutathione resin with 1.6 nmol of proteins at
4 °C for 4 h. The resin was then washed twice and resuspended
to 25% slurry in washing buffer. Approximately 80-90% GST or GST
fusion proteins bound to the resin, which is equivalent to at least 80 pmol GST or GST fusion proteins/50 µl resin suspension.
Brain cytosol was prepared by following the protocols described by
Slepnev et al. (38). Phosphorylation was performed by incubating the cytosol at 30 °C for 30 min in the presence of 2 mM ATP, 2 mM MgCl2, 0.2-10 µg/ml
either WT or DF GST-Mnbk/Dyrk1A (if needed), and a mixture of
phosphatase inhibitors (2 µM cyclosporine, 0.2 µM okadaic acid, and 1 mM sodium
orthovanadate). After stopping the reaction by the addition of 5 mM EDTA, the treated cytosol was then subjected to binding
assay by mixing 0.5 ml of cytosol with 50 µl of glutathione resin
precoated with GST proteins for 16 h at 4 °C. Bound dynamin was
eluted from the resin and determined as described.
 |
RESULTS |
Development of the Mnbk/Dyrk1A Solid-phase Kinase
Assay--
A rapid and reliable assay is essential for the
purification of kinase substrates. Therefore, a solid-phase kinase
assay was developed for Mnbk/Dyrk1A by adapting the combination of two
previously described protocols (36, 39). Briefly, proteins to be tested are separated by SDS-PAGE, transferred onto a polyvinylidene difluoride membrane, blocked by bovine serum albumin, and then subjected to
Mnbk/Dyrk1A phosphorylation in the presence of
[
-32P]ATP. Under the conditions specified, the method
detected 10 ng of immobilized myelin basic protein (MBP) (Fig.
1).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 1.
Phosphorylation of MBP by the solid-phase
Mnbk/Dyrk1A assay. Different amounts of MBP were separated on a
10% Tricine-SDS gel, transferred to a polyvinylidene difluoride
membrane, and phosphorylated as described under "Materials and
Methods." Autoradiography was performed by exposing Kodak XAR 5 film
with an intensifying screen for 3 h at 80 °C. The amount of
MBP used in lanes 1-8 was 2.5, 5, 10, 20, 40, 80, 160, and
320 ng, respectively.
|
|
Detection of Mnbk/Dyrk1A Substrates in Rat
Brain--
Rat brain aqueous extract was prepared and subjected to the
solid-phase kinase assay. As shown in Fig.
2A, Mnbk/Dyrk1A prominently phosphorylated two proteins in adult rat brain: a 100-kDa protein (Sub-100) and a 140-kDa protein (Sub-140). In addition, several minor
phosphorylated proteins were also detected in the assay. Phosphorylation of these two proteins did not appear to be due to
autophosphorylation because no labeled protein was visible when the
membrane was incubated without kinase (Fig. 2B). SDS (1%)
extracted a few additional proteins that can be phosphorylated by
Mnbk/Dyrk1A (Fig. 2C); nevertheless, Sub-100 and Sub-140
still represent the major cellular targets of Mnbk/Dyrk1A. In this
study, we will concentrate on the identification and characterization of the 100-kDa Mnbk/Dyrk1A substrate.

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 2.
Phosphorylation of rat brain soluble extract
and SDS extract by the solid-phase Mnbk/Dyrk1A assay. Soluble and
SDS extracts were prepared from adult rat brains and subjected to the
solid-phase kinase assay (30 µg of total protein) as described under
"Materials and Methods." A, phosphorylation of soluble
extract; B, phosphorylation of soluble extract without
kinase; C, phosphorylation of SDS extract with kinase.
|
|
Purification of the 100-kDa Mnbk/Dyrk1A Substrate,
Sub-100--
By using the solid-phase kinase assay to monitor the
process of Sub-100 purification (see "Materials and Methods"),
Sub-100 was purified from adult rat brains under native conditions
(Fig. 3A). Like the denatured
Sub-100 used in the solid-phase assay, purified Sub-100 was efficiently
phosphorylated by Mnbk/Dyrk1A under native conditions. This result
suggests that the Mnbk/Dyrk1A phosphorylation site on Sub-100 is
naturally exposed. The extent of phosphate incorporation was highly
dependent on the GST-Mnbk/Dyrk1A concentration (Fig. 3B).
The molar ratio of phosphate incorporation would only reach a certain
level if Sub-100 was incubated with a low amount of kinase. On the
other hand, the ratio could easily exceed 1 if a high level of kinase
was used for the assay. By using native Sub-100 as a substrate and a
constant kinase level of 0.05 µg/assay, the apparent
Km and kcat values of the
reaction were determined to be 1.17 µM and 0.15 s
1, respectively.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Purification and phosphorylation of native
Sub-100 by GST-Mnbk/Dyrk1A. A, Coomassie Blue staining
of purified Sub-100. B, time course of phosphate
incorporation. Purified native Sub-100 (1 µg) was phosphorylated by
GST-Mnbk/Dyrk1A (0.05-0.8 µg) in the solution kinase assay in a
total volume of 30 µl. At the indicated times, a 5-µl aliquot of
labeled Sub-100 was withdrawn and precipitated with silicotungstic acid
and quantified as described under "Materials and Methods." Parallel
experiments, performed with Sub-100 alone and with kinase alone, were
used for background correction. The numbers represent the average of
three independent experiments. The amounts of GST-Mnbk/Dyrk1A used for
the assays were 0.05 ( ), 0.1 ( ), 0.4 ( ), and 0.8 µg
( ).
|
|
Identification of Sub-100 kDa as Dynamin 1--
Because Sub-100
could not be sequenced directly, it was first cleaved with cyanogen
bromide. Cyanogen bromide cleaves Sub-100 into eight visible fragments
with apparent molecular masses ranging from 4 to 16 kDa (4.5, 5, 6, 8, 10, 11, 13, and 16 kDa) when analyzed on a 12.5% SDS-Tricine gel
(polypeptides smaller than 4 kDa were not resolved by this gel). Edman
degradation showed that the largest fragment, the 16-kDa polypeptide,
contained the sequence (M)(T/E)DLIPLVNRL. BLAST search identified this
fragment as unique to rat dynamin 1. This 16-kDa fragment corresponds
to the 135-residue peptide (calculated mass, 14,528 Da) resulting from
cyanogen bromide cleavage at methionine-4 and methionine-140 of dynamin
1. Then the 6-kDa peptide was sequenced and found to contain the
sequence (M)DEGXDAR. This sequence again matches dynamin, but it is
common to all dynamin isoforms. Dynamins are encoded by three distinct
genes, each expressed as several closely related spliced variants (40).
We inferred that Sub-100 is primarily, if not exclusively, dynamin 1 based on the following reasoning. First, Sub-100 matches dynamin 1 in size and contains a dynamin 1-specific peptide. Second, dynamin 1 is
the dominating isoform in brain, the source for Sub-100. Third, Sub-100
precipitates at pH 6.5 ("Materials and Methods"), which is
consistent with the isoelectric point of dynamin 1 but not with that of
dynamin 2 and dynamin 3. Fourth, Sub-100 lacks the larger cyanogen
bromide-cleavable peptide (calculated mass, 16,825 Da) predicated from
the sequence of dynamin 2, which indicates that Sub-100 does not
contain a significant amount of dynamin 2. For convenience, Sub-100
will be referred to as dynamin 1.
Phosphorylation of E. coli-expressed Dynamin Isoforms by
Mnbk/Dyrk1A--
To confirm that dynamin 1 is an
Mnbk/Dyrk1A substrate, a GST fusion clone containing the dynamin 1aa
isoform was constructed from plasmid pCMV96-7 (33). Upon induction, the
clone produced a 125-kDa protein (Fig.
4A, 1), which can be
recognized by anti-human dynamin monoclonal antibody Hudy-1 (37) (data
not shown). This protein was then analyzed by the solid-phase kinase
assay. As shown in Fig. 4B, 1, GST-dynamin 1aa was
phosphorylated by Mnbk/Dyrk1A similarly to the purified rat brain
dynamin 1. This observation substantiates the conclusion that dynamin
1aa is a Mnbk/Dyrk1A substrate. In addition to isoform 1aa, Mnbk/Dyrk1A
also phosphorylated dynamin-1ab (data not shown) and dynamin 2aa (Fig.
4, A and B, 2) under the same condition. Dynamin
1ab is identical to the 1aa isoform except for 20 or so residues at the
C terminus, whereas dynamin 2 shares about 78% overall homology with
dynamin 1. In contrast, human MxA protein, a distant dynamin homologue
that is inducible by type 1 interferon and some viruses (34), was not a
Mnbk/Dyrk1A substrate (Fig. 4, A and B,
3).

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 4.
The production and phosphorylation of dynamin
isoforms and the MxA protein. GST fusion proteins were expressed
in E. coli strain BL21(DE3) as described under "Materials
and Methods." Cells from 200-µl aliquots were collected by
centrifugation, boiled in 0.5 volume of SDS-PAGE loading buffer, and
electrophoresed on duplicate 8% Tricine-SDS gels. One gel was stained
with Coomassie Blue (A), and the other was blotted and
subjected to solid-phase Mnbk/Dyrk1A phosphorylation (B).
IPTG , controls; IPTG +,
isopropyl- -D-thiogalactopyranoside-induced samples.
Asterisks indicate the induced GST fusion proteins.
1, GST-dynamin 1aa; 2, GST-dynamin 2aa;
3, GST-MxA.
|
|
Effects of Mnbk/Dyrk1A Phosphorylation on the
Interaction of Purified Dynamin 1 with Amphiphysin--
The binding of
dynamin to amphiphysin is required for incorporation of dynamin into
endocytic complexes (41). The interaction is inhibited when dynamin is
phosphorylated (38). However, the kinase (or kinases) responsible for
the dynamin phosphorylation has not been identified. Therefore, it was
of interest to test whether Mnbk/Dyrk1A could assume the role of the
unknown kinase. To perform the experiment, purified rat brain dynamin 1 was phosphorylated by Mnbk/Dyrk1A in solution and then allowed to bind
to the immobilized GST fusion protein containing the SH3 domain of
human amphiphysin 1, GST-Amp(SH3). After recovering the immobilized
GST-Amp(SH3), the presence of dynamin in the complex was determined
with the anti-dynamin antibody Hudy-1. As expected, GST-Amp(SH3) bound dynamin 1 as opposed to the GST control (Fig.
5A). Interestingly, the
ability to bind GST-Amp(SH3) was reduced when dynamin was phosphorylated by GST-Mnbk/Dyrk1A before the assay (Fig.
5A). The reduction in binding required the dynamin
phosphorylating activity of GST-Mnbk/Dyrk1A because DF, a mutant
protein possessing a fraction of catalytic activity of the WT (2),
had little inhibitory effect on the binding (Fig.
5A). The reduction in the binding could not be attributed to
the direct competition from GST-Mnbk/Dyrk1A because it did not form a
stable complex with dynamin 1 under the assay conditions (Fig.
6). Because antibody Hudy-1 cannot
distinguish between Mnbk/Dyrk1A-phosphorylated and nonphosphorylated
dynamin 1 (Fig. 7), it further ruled out
the possibility that the reduction observed (Fig. 5A) was
caused by the inability of Hudy-1 to recognize the
Mnbk/Dyrk1A-phosphorylated dynamin 1.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Interaction of Mnbk/Dyrk1A-phosphorylated
dynamin with the SH3 domain of amphiphysin 1. A,
amphiphysin binding property of phosphorylated dynamin. Purified
dynamin 1 (1 µg) was phosphorylated by 0.1 µg of Mnbk/Dyrk1A and
then bound to glutathione resin precoated with GST or GST-Amp(SH3) as
described under "Materials and Methods." After binding, glutathione
resin was collected, and co-precipitated dynamin was detected by
anti-dynamin antibody. Dynamin incubated with ATP but without the
addition of kinase was used as the phosphorylation control.
GST, experiment performed with GST-coated resin;
Amp(SH3), experiment performed with GST-Amp(SH3)-coated
resin. ATP, control phosphorylation with ATP alone;
DF, phosphorylated by GST-Mnbk/Dyrk1A double mutant plus
ATP; WT, phosphorylated by wild-type GST-Mnbk/Dyrk1A plus
ATP. Bars, which have been normalized to the ATP control
(ATP control = 1), represent the mean ± S.D. of three
independent experiments. A paired t test was performed for
the treatment pairs ATP-WT, DF-WT, and ATP-DF. ATP and DF were found to
be statistically different from WT (*, p < 0.01),
whereas no difference was found between ATP and DF. B,
amphiphysin binding of dynamin phosphorylated by different
concentrations of Mnbk/Dyrk1A. Purified dynamin 1 (1 µg) was
phosphorylated with either 0, 0.1, 0.4, or 0.8 µg of WT Mnbk/Dyrk1A
and then subjected to the amphiphysin binding assay as described above.
Dynamin 1 treated with 0. 1 or 0.8 µg of WT Mnbk/Dyrk1A was found to
be significantly different from the untreated control in binding
amphiphysin (*, p < 0.01, paired t
test).
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 6.
Binding assay of dynamin 1 to
GST-Mnbk/Dyrk1A. Binding was performed by mixing 1 µg of dynamin
1 and 10 µg of GST-Mnbk/Dyrk1A in a buffer containing 25 mM Tris, pH 7.4, 150 mM NaCl, 2 mM
EDTA, and 1 mM DTT. GST-Mnbk/Dyrk1A in the binding mixture
was subsequently precipitated with glutathione resin, and the presence
of dynamin in the complex was detected by anti-dynamin antibody as
described under "Materials and Methods." Negative and positive
controls were performed similarly by using GST and GST-Amp(SH3),
respectively, as the binding agents. Lane 1, GST; lane
2, GST-Mnbk/Dyrk1A; lane 3, GST-Amp(SH3).
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Detection of control and
Mnbk/Dyrk1A-phosphorylated dynamin by anti-dynamin antibody
Hudy-1. Purified dynamin 1 (1 µg) was phosphorylated by 0.1 µg
of Mnbk/Dyrk1A and then subjected to Western blotting analysis by
anti-dynamin antibody Hudy-1 as described under "Materials and
Methods." Each lane presents 20 ng of control (C) and
Mnbk/Dyrk1A-phosphorylated dynamin (P).
|
|
Intriguingly, if dynamin was phosphorylated with higher concentrations
of Mnbk/Dyrk1A (Fig. 5B), specifically with an amount of
Mnbk/Dyrk1A that was able to promote >1 mol phosphate
incorporation/mol of dynamin (Fig. 3B), the phosphorylation
resulted in enhancement rather than reduction of the binding of dynamin
to GST-Amp(SH3). This observation suggests that Mnbk/Dyrk1A
phosphorylation plays a dual role in regulating the amphiphysin binding
property of dynamin.
Effects of Mnbk/Dyrk1A Phosphorylation on the
Interaction of Dynamin with Amphiphysin in Crude Brain Extract--
We
further examined the effects of Mnbk/Dyrk1A phosphorylation on
dynamin-amphiphysin binding in crude brain extracts. A low-salt aqueous
extract (cytosol) containing many proteins involved in endocytosis was
prepared from adult rat brains by following the protocols of Slepnev
et al. (38). After incubation with ATP and phosphatase
inhibitors, cytosol was mixed with resin-immobilized GST-Amp(SH3), and
the amount of dynamin co-precipitated with the resin was analyzed. As
opposed to the Triton X-100 extract (38), the addition of ATP and
phosphatase inhibitors did not cause an appreciable reduction in the
binding of dynamin to GST-Amp(SH3) (data not shown). This result
suggests that the cytosol fraction lacked the necessary kinase to
modulate the binding of dynamin to GST-Amp(SH3). Therefore, the cytosol
was used for testing the effects of GST-Mnbk/Dyrk1A supplementation on
the binding of dynamin to GST-Amp(SH3). Similarly to purified dynamin 1 (Fig. 5), the addition of the wild-type GST-Mnbk/Dyrk1A, ATP, and
phosphatase inhibitors inhibited the binding of dynamin to GST-Amp(SH3)
(Fig. 8). Again, GST-DF had little effect
on the binding, indicating that the kinase activity is essential for
the inhibition of dynamin-amphiphysin binding (Fig. 8). This result
shows that Mnbk/Dyrk1A phosphorylation can inhibit dynamin-amphiphysin
binding in a defined as well as in a more complex system, such as crude
brain extract. When cytosol was treated with a higher concentration of
Mnbk/Dyrk1A, more dynamin was found to bind GST-Amp(SH3) than the
untreated control (data not shown). Thus, the dual effect of
Mnbk/Dyrk1A phosphorylation on dynamin and GST-Amp(SH3) binding was
also observed in crude extract.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
The effects of GST-Mnbk/Dyrk1A
phosphorylation on dynamin 1 binding to amphiphysin 1, endophilin 1, and Grb2 in brain cytosolic extract. Rat brain cytosol was
incubated with either WT GST-Mnbk/Dyrk1A or DF in the presence of ATP
and phosphatase inhibitors as described under "Materials and
Methods." An extract incubated without kinase (ATP) was
used as a phosphorylation control. After reaction, samples were mixed
with glutathione resin precoated with either GST-Amp(SH3),
GST-endophilin 1, or GST-Grb2 and processed as described in the Fig. 7
legend. The volume of eluted sample used for Western blotting analysis
was adjusted to give a roughly equal intensity of the dynamin band.
Amp(SH3), Endophilin 1, and Grb 2 represent
experiments performed with glutathione resin coated with GST-Amp(SH3),
GST-endophilin 1, and GST-Grb2, respectively. ATP, extract
incubated with ATP and phosphatase inhibitors but no kinase;
DF, phosphorylated by GST-Mnbk/Dyrk1A double mutant plus ATP
and phosphatase inhibitors; WT, phosphorylated by wild-type
GST-Mnbk/Dyrk1A plus ATP and phosphatase inhibitors. Bars, which have
been normalized to the ATP control (ATP control = 1) in each set
of the binding assay, represent the mean ± S.D. of three
independent experiments. A paired t test was performed for
the treatment pairs ATP-WT, DF-WT, and ATP-DF. In all three binding
assays, statistical differences were found between ATP (or DF) and WT
(*, p < 0.01), but not between ATP and DF.
|
|
Effects of Mnbk/Dyrk1A Phosphorylation on the
Interaction of Dynamin with Endophilin 1 and Grb2 in Crude Brain
Extract--
We then analyzed whether Mnbk/Dyrk1A phosphorylation
affected the binding of dynamin to other SH3 domain-containing
proteins. Endophilin 1 (SH3p4) (42) and Grb2 (43) were chosen for the study because of their roles in mediating the cellular function of
dynamin. To perform the assay, GST fusion of full-length human endophilin 1 and Grb2 was prepared, immobilized onto resin, and used as
the affinity matrix for binding dynamin. Both endophilin 1 and Grb2
bound dynamin under the same assay conditions used for analyzing
dynamin-GST-Amp(SH3) binding (Fig. 8). Similarly to GST-Amp(SH3),
Mnbk/Dyrk1A phosphorylation reduced the binding of dynamin to
endophilin 1 (Fig. 8). In contrast, Mnbk/Dyrk1A phosphorylation has an
opposite effect on dynamin-Grb2 binding because it enhanced rather than
reduced the binding of dynamin to Grb2 (Fig. 8). GST-DF had little
effect on the binding of dynamin to either endophilin 1 or Grb2 (Fig.
8). Again, it showed that an active kinase activity was required for
modifying the property of dynamin. However, the dual effect of
Mnbk/Dyrk1A phosphorylation on dynamin was not observed for binding to
endophilin 1 and Grb2 (data not shown).
 |
DISCUSSION |
A solid-phase kinase assay for analyzing substrates of Mnbk/Dyrk1A
was developed and used to probe rat brain extract (Fig. 1). Two
cytosolic substrates of Mnbk/Dyrk1A, one of 100 kDa and the other of
140 kDa, were revealed by the assay (Fig. 2). The 100-kDa protein was
purified and determined to be dynamin 1. It was further confirmed that
dynamin 1 is a Mnbk/Dyrk1A substrate by showing that recombinant
GST-dynamin 1 proteins (both the dynamin 1aa and 1ab isoforms) were
efficiently phosphorylated by Mnbk/Dyrk1A (Fig. 4). In addition to
dynamin 1, Mnbk/Dyrk1A was also shown to phosphorylate recombinant
GST-dynamin 2aa but not the human MxA protein in the solid-phase assay
(Fig. 4). Mnbk/Dyrk1A is capable of phosphorylating native dynamin
(Fig. 3B), indicating that phosphorylation sites are
naturally accessible to the kinase. The extent of phosphorylation was
highly dependent on the amounts of input kinase (Fig. 3B).
For example, a high phosphorylation ratio could not be achieved even
with prolonged incubation if one started with a low level of kinase
(Fig. 3B). This phenomenon may be attributed to the fact
that purified GST-Mnbk/Dyrk1A is rather unstable in vitro.
Dynamin can be phosphorylated to >1 mol phosphate/mol protein if
sufficient kinase is present. The observation implies that dynamin may
contain multiple Mnbk/Dyrk1 phosphorylation sites. By using a constant
level of 0.05 µg of Mnbk/Dyrk1A, the Km and
kcat values of the phosphorylation reaction were
determined to be 1.17 µM and 0.15 s
1,
respectively. These values are similar to those of Mnbk/Dyrk1A phosphorylation of MBP (25).
Dynamin is a large GTPase known to play an essential role in
clathrin-mediated endocytosis and synaptic vesicle recycling (40, 41,
44). It has been proposed that dynamin, which assembled around the
necks of invaginated clathrin-coated pits, is responsible for
constricting and pinching coated vesicles from the plasma membrane
through a concerted conformational change (45-48). However, evidence
also exists that dynamin may function as a regulator in
receptor-mediated endocytosis rather than as a mechanochemical enzyme
directly involved in generating vesicles (49). Dynamins consist of four
recognizable structural domains: a highly conserved GTPase domain in
the first 300 residues, a pleckstrin homology domain, a GTPase effector
domain, and the least conserved proline-rich domain at the C terminus
(40, 41, 44). Dynamin binds either in vitro or in
vivo to a large array of cellular components, including proteins
participating in endocytosis, maintenance of the cytoskeleton, and
signal transduction, primarily through its pleckstrin homology domain
and proline-rich domain (40, 41, 44).
Mnbk/Dyrk1A phosphorylation of dynamin 1 appears to have physiological
significance. First, dynamin 1 was phosphorylated by Mnbk/Dyrk1A in its
native state to a stoichiometric ratio (Fig. 3B). Most
importantly, the phosphorylation inhibited the binding of dynamin to
amphiphysin 1 (Fig. 5A). Both amphiphysin and dynamin 1 are
highly enriched in nerve terminals, and they are the major binding
partners to each other (50). By virtue of its ability to interact with
various components of endocytic complexes, such as clathrin, adaptins,
synaptojanin, and others, amphiphysin appears to function as an adapter
protein for incorporating dynamin into the endocytic apparatus (41,
51). In neuronal cells, dynamin undergoes an
activity-dependent phosphorylation-dephosphorylation cycle:
it is phosphorylated when the cell is in the resting state and is
rapidly dephosphorylated when the cell is depolarized (52, 53). It has
been shown that phosphorylation of dynamin inhibits its interaction
with amphiphysin and the subsequent incorporation into the endocytic
apparatus (38). The kinase (or kinases) responsible for the
phosphorylation has not been identified. Our results demonstrate that
Mnbk/Dyrk1A can fulfill the role of the unidentified kinase in
vitro.
Mnbk/Dyrk1A appears to play a dual role in mediating dynamin and
amphiphysin binding (Fig. 5B). When dynamin was
phosphorylated by a low concentration of Mnbk/Dyrk1A, the
dynamin-amphiphysin binding was inhibited by the phosphorylation.
However, if dynamin was phosphorylated with a larger amount of
Mnbk/Dyrk1A, the phosphorylation resulted in the enhancement of dynamin
binding to amphiphysin. The amount of Mnbk/Dyrk1A needed for the
changeover appeared to be between 0.1 and 0.4 µg Mnbk/Dyrk1A/µg
dynamin 1 (Fig. 5B). This level of kinase is roughly
equivalent to the concentration required for promoting >1 mol
phosphate incorporation/mol dynamin (Fig. 3B). The level of
phosphate incorporation and the ability to bind amphiphysin must be
related; therefore, we speculate that dynamin may contain two
Mnbk/Dyrk1A phosphorylation sites, which are phosphorylated by
Mnbk/Dyrk1A with different rates (or recognized by Mnbk/Dyrk1A with
different affinities). Phosphorylation at the fast site can be achieved
with low kinase concentrations and accounts for the reduction in
amphiphysin binding, whereas phosphorylation at the slow site can only
be obtained with high kinase concentrations and can reverse the effects
of the fast site phosphorylation. This hypothesis explains the dual
effect of Mnbk/Dyrk1A phosphorylation. Apparently, the slow site
phosphorylation does not influence the binding of dynamin to endophilin
1 and Grb2 because these bindings are not affected by the level of
dynamin phosphorylation. Furthermore, the determined
Km and kcat values probably
represent the phosphorylation of the fast site because the experiments
were performed with a low concentration of kinase. Because the level of
residual phosphorylation in purified rat dynamin 1 was not determined,
alternatively, the property of dynamin 1 phosphorylated with varying
amounts of Mnbk/Dyrk1A may reflect distinct sensitivities of different
phosphorylation sites to dephosphorylation during dynamin 1 purification.
Mnbk/Dyrk1A phosphorylation also reduced the interaction of dynamin
with endophilin 1 (Fig. 8). Like amphiphysin, endophilin 1 is highly
enriched in nerve terminals (42, 54). Studies suggest that this protein
may be involved in multiple steps of synaptic vesicle recycling,
ranging from clathrin-coated vesicle invagination to fission and
possibly to the uncoating of vesicles (55, 56). To accomplish these
functions, endophilin 1 appears to require the lysophosphatidic acid
acyltransferase activity of endophilin 1 as well as the direct
participation of dynamin (57). The finding that Mnbk/Dyrk1A
phosphorylation inhibits dynamin and endophilin1 binding further
suggests a potential role for the kinase in the endocytic pathways.
Mnbk/Dyrk1A phosphorylation enhanced the interaction of dynamin with
Grb2. The role of the Grb2 in tyrosine kinase signal transduction is
well established (58). Grb2 consists solely of SH2 and SH3 domains and
serves as an adaptor linking different signal transduction
pathways, such as receptor tyrosine kinases and the mitogen-activated
protein kinase cascade. The ability of Grb2 to bind dynamin
implies an involvement of dynamin in the tyrosine kinase signaling
pathway. Studies have shown that the dynamin-Grb2 interaction recruits
dynamin to the insulin signaling complex and subsequently promotes
tyrosine phosphorylation of dynamin (59, 60). Furthermore, dynamin may
also participate in the signaling pathways of G-protein-coupled
receptors through interaction with Grb2. G-protein-coupled receptor,
such as
2-adrenergic receptor, is known to associate with Grb2 as a
result of tyrosine phosphorylation on G-protein-coupled receptor (61).
Conceivably, the dynamin-Grb2 interaction could bring dynamin to
phosphorylated G-protein-coupled receptor and promote receptor
internalization, which may subsequently lead to termination of receptor
signaling (61) or stimulation of the downstream kinase cascade for some receptors (62). These connections indicate that Mnbk/Dyrk1A may
regulate the signal transduction pathway of receptors through dynamin phosphorylation.
Mnbk/Dyrk1A has been shown to be a proline-directed kinase (25). This
conclusion is consistent with our preliminary data showing that all
Mnbk/Dyrk1A phosphorylation sites appear to be localized in the
proline-rich domain of dynamin
1.2 This may also explain why
MxA, a protein lacking proline-rich domain, was not a Mnbk/Dyrk1A
substrate (Fig. 4). With the use of histone and synthetic combinatorial
peptides, it was determined that Mnbk/Dyrk1A preferentially
phosphorylates a site with the sequence RPX(S/T)P (25).
Dynamin 1xa isoforms contain the sequence 854RPESP858, localized near the C-terminal end
(33, 53). Interestingly, the sequence is located about 14 residues away
from the overlapping amphiphysin and endophilin 1 binding sites of
dynamin 1 (63, 64). Nevertheless, it should be pointed out that
although both dynamin 1ab and dynamin 2aa isoforms are efficiently
phosphorylated by Mnbk/Dyrk1A in the solid-phase assay, the sequence
RPX(S/T)P is not present in either isoform. Clearly,
Mnbk/Dyrk1A allows certain degrees of variation for its phosphorylation
site. Work to map the Mnbk/Dyrk1A phosphorylation sites on dynamin is
currently under way.
On the basis of its ability to phosphorylate dynamin and modulate its
interaction with amphiphysin and endophilin, we suggest that
Mnbk/Dyrk1A is involved in regulating synaptic vesicle recycling. Disrupting the function of dynamin has been shown to affect the synaptic activity required for memory retrieval in
Drosophila (65, 66). Our findings shed light on animal model
studies reporting that either over- or underexpression of the
Mnbk/Dyrk1A gene caused behavioral,
learning, and cognitive defects (1, 23, 24).
 |
ACKNOWLEDGEMENTS |
We thank Dr. Thomas C. Südhof (Howard
Hughes Medical Institute, University Texas Southwestern Medical Center)
for providing dynamin clones (pCMV96-7 and pCMV96-15). We also thank
Drs. Robert Denman, Carl Dobkin, David Miller, and Noriko Murakami for
critical reading of the manuscript and Maureen Marrow for editorial
assistance. Y.-W. H. thanks Drs. Ming-Ta Hsu (Department of Life
Science, National Yang-Ming University), Yun-Chia Chou (Institute of
Physiology, National Yang-Ming University), and Chen-Kung Chou (Taipei
Veterans General Hospital) for support during his tenure in Taiwan.
 |
FOOTNOTES |
*
This work was supported in part by the New York State Office
of Mental Retardation and Developmental Disabilities and by National Institutes of Health Grants HD35870 (to Y.-W. H.) and HD38295 (to
Y.-W. H.). Additional support was provided by the Yen Tjing Ling
Medical Foundation (Taiwan) and by Grant NSC-87-2312-B-010-005 (to
Y.-W. H.) from the National Science Council (Taiwan).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Present address: Dept. of Aquaculture, National Suao Marine & Fishery Senior Vocational School, Suao, Taiwan.
Present address: 6010 Summerhill Dr., Hudsonville, MI 49426.

To whom correspondence should be addressed: Molecular Biology
Dept., New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Rd., Staten Island, NY 10314. Tel.: 718-494-5337; Fax: 718-494-5905; E-mail:
hwang@postbox.csi.cuny.edu.
Published, JBC Papers in Press, March 4, 2002, DOI 10.1074/jbc.M111101200
2
J. Y. Huang, M.-C. Chen-Hwang, N. Murakami, R. Wang, and Y. W. Hwang.
 |
ABBREVIATIONS |
The abbreviations used are:
Mnbk, minibrain
kinase;
Amp(SH3), Src homology 3 domain of amphiphysin 1;
DTT, dithiothreitol;
Dyrk, dual specificity Yak-related kinase;
FPLC, fast
protein liquid chromatography;
GST, glutathione
S-transferase;
MBP, myelin basic protein;
SH, Src homology;
WT, wild type;
MES, 4-morpholineethanesulfonic acid;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.
 |
REFERENCES |
| 1.
|
Tejedor, F.,
Zhu, X. R.,
Kaltenbach, E.,
Ackermann, A.,
Baumann, A.,
Canal, I.,
Heisenberg, M.,
Fischbach, K. F.,
and Pongs, O.
(1995)
Neuron
14,
287-301[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Kentrup, H.,
Becker, W.,
Heukelbach, J.,
Wilmes, A.,
Schürmann, A.,
Huppertz, C.,
Kainulainen, H.,
and Joost, H. G.
(1996)
J. Biol. Chem.
271,
3488-3495[Abstract/Free Full Text]
|
| 3.
|
Guimerà, J.,
Casas, C.,
Pucharcòs, C.,
Solans, A.,
Domènech, A.,
Planas, A. M.,
Ashley, J.,
Lovett, M.,
Estivill, X.,
and Pritchard, M. A.
(1996)
Hum. Mol. Genet.
5,
1305-1310[Abstract/Free Full Text]
|
| 4.
|
Shindoh, N.,
Kudoh, J.,
Maeda, H.,
Yamaki, A.,
Minoshima, S.,
Shimizu, Y.,
and Shimizu, N.
(1996)
Biochem. Biophys. Res. Commun.
225,
92-99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Song, W. J.,
Sternberg, L. R.,
Kasten-Sportès, C.,
Van Keuren, M. L.,
Chung, S. H.,
Slack, A.,
Miller, D. E.,
Glover, T. W.,
Chiang, P. W.,
Lou, L.,
and Kurnit, D. M.
(1996)
Genomics
38,
331-339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Becker, W.,
and Joost, H. G.
(1999)
Prog. Nucleic Acid Res. Mol. Biol.
62,
1-17[Medline]
[Order article via Infotrieve]
|
| 7.
|
Garrett, S.,
and Broach, J. R.
(1989)
Genes Dev.
3,
1336-1348[Abstract/Free Full Text]
|
| 8.
|
Becker, W.,
Weber, Y.,
Wetzel, K.,
Eirmbter, K.,
Tejedor, F. J.,
and Joost, H. G.
(1998)
J. Biol. Chem.
273,
25893-25902[Abstract/Free Full Text]
|
| 9.
|
Moilanen, A. M.,
Karvonen, U.,
Poukka, H.,
Janne, O. A.,
and Palvimo, J. J.
(1998)
Mol. Biol. Cell
9,
2527-2543[Abstract/Free Full Text]
|
| 10.
|
Hofmann, T. G.,
Mincheva, A.,
Lichter, P.,
Droge, W.,
and Lienhard Schmitz, M.
(2000)
Biochimie (Paris)
82,
1123-1127
|
| 11.
|
Lee, K.,
Deng, X.,
and Friedman, E.
(2000)
Cancer Res.
60,
3631-3637[Abstract/Free Full Text]
|
| 12.
|
Shang, E.,
Wang, X.,
Huang, J.,
Yoshida, W.,
Kuroiwa, A.,
and Wolgemuth, D. J.
(2000)
Mol. Reprod. Dev.
55,
372-378[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Bahler, J.,
and Nurse, P.
(2001)
EMBO J.
20,
1064-1073[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Hanks, S. K.,
Quinn, A. M.,
and Hunter, T.
(1988)
Science
241,
42-52[Abstract/Free Full Text]
|
| 15.
|
Dingwall, C.,
and Laskey, R. A.
(1991)
Trends Biochem. Sci.
16,
478-481[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Song, W. J.,
Chung, S. H.,
and Kurnit, D. M.
(1997)
Biochem. Biophys. Res. Commun.
231,
640-644[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Guimerà, J.,
Pritchard, M.,
Nadal, M.,
and Estivill, X.
(1997)
Cytogenet. Cell Genet.
77,
182-184[Medline]
[Order article via Infotrieve]
|
| 18.
|
Ohira, M.,
Seki, N.,
Nagase, T.,
Suzuki, E.,
Nomura, N.,
Ohara, O.,
Hattori, M.,
Sakaki, Y.,
Eki, T.,
Murakami, Y.,
Saito, T.,
Ichikawa, H.,
and Ohki, M.
(1997)
Genome Res.
7,
47-58[Abstract/Free Full Text]
|
| 19.
|
Chen, H.,
and Antonarakis, S. E.
(1997)
Hum. Genet.
99,
262-265[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Hattori, M.,
Fujiyama, A.,
Taylor, T. D.,
Watanabe, H.,
Yada, T.,
Park, H. S.,
Toyoda, A.,
Ishii, K.,
Totoki, Y.,
Choi, D. K.,
Soeda, E.,
Ohki, M.,
Takagi, T.,
Sakaki, Y.,
Taudien, S.,
Blechschmidt, K.,
Polley, A.,
Menzel, U.,
Delabar, J.,
Kumpf, K.,
Lehmann, R.,
Patterson, D.,
Reichwald, K.,
Rump, A.,
Schillhabel, M.,
Schudy, A.,
Zimmermann, W.,
Rosenthal, A.,
Kudoh, J.,
Schibuya, K.,
Kawasaki, K.,
Asakawa, S.,
Shintani, A.,
Sasaki, T.,
Nagamine, K.,
Mitsuyama, S.,
Antonarakis, S. E.,
Minoshima, S.,
Shimizu, N.,
Nordsiek, G.,
Hornischer, K.,
Brant, P.,
Scharfe, M.,
Schon, O.,
Desario, A.,
Reichelt, J.,
Kauer, G.,
Blocker, H.,
Ramser, J.,
Beck, A.,
Klages, S.,
Hennig, S.,
Riesselmann, L.,
Dagand, E.,
Haaf, T.,
Wehrmeyer, S.,
Borzym, K.,
Gardiner, K.,
Nizetic, D.,
Francis, F.,
Lehrach, H.,
Reinhardt, R.,
and Yaspo, M. L.
(2000)
Nature
405,
311-319[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Kola, I.,
and Hertzog, P. J.
(1998)
Curr. Opin. Genet. Dev.
8,
316-321[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Rahmani, Z.,
Lopes, C.,
Rachidi, M.,
and Delabar, J. M.
(1998)
Biochem. Biophys. Res. Commun.
253,
514-518[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Smith, D. J.,
Stevens, M. E.,
Sudanagunta, S. P.,
Bronson, R. T.,
Makhinson, M.,
Watabe, A. M.,
O'Dell, T. J.,
Fung, J.,
Weier, H. U.,
Cheng, J. F.,
and Rubin, E. M.
(1997)
Nat. Genet.
16,
28-36[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Altafaj, X.,
Dierssen, M.,
Baamonde, C.,
Martí, E.,
Visa, J.,
Guimerà, J.,
Oset, M.,
González, J. R.,
Flórez, J.,
Fillat, C.,
and Estivill, X.
(2001)
Hum. Mol. Genet.
10,
1915-1923[Abstract/Free Full Text]
|
| 25.
|
Himpel, S.,
Tegge, W.,
Frank, R.,
Leder, S.,
Joost, H. G.,
and Becker, W.
(2000)
J. Biol. Chem.
275,
2431-2438[Abstract/Free Full Text]
|
| 26.
|
Woods, Y. L.,
Cohen, P.,
Becker, W.,
Jakes, R.,
Goedert, M.,
Wang, X.,
and Proud, C. G.
(2001)
Biochem. J.
355,
609-615[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Woods, Y. L.,
Rena, G.,
Morrice, N.,
Barthel, A.,
Becker, W.,
Guo, S.,
Unterman, T. G.,
and Cohen, P.
(2001)
Biochem. J.
355,
597-607[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Yang, E. J.,
Ahn, Y. S.,
and Chung, K. C.
(2001)
J. Biol. Chem.
276,
39812-39824[Abstract/Free Full Text]
|
| 29.
|
Sung, Y. J.,
Carter, M.,
Zhong, J. M.,
and Hwang, Y. W.
(1995)
Biochemistry
34,
3470-3477[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Yamamoto, R., Li, X.,
Winter, S.,
Francke, U.,
and Kilimann, M. W.
(1995)
Hum. Mol. Genet.
4,
265-268[Abstract/Free Full Text]
|
| 31.
|
So, C. W.,
Caldas, C.,
Liu, M. M.,
Chen, S. J.,
Huang, Q. H., Gu, L. J.,
Sham, M. H.,
Wiedemann, L. M.,
and Chan, L. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2563-2568[Abstract/Free Full Text]
|
| 32.
|
Giachino, C.,
Lantelme, E.,
Lanzetti, L.,
Saccone, S.,
Bella Valle, G.,
and Migone, N.
(1997)
Genomics
41,
427-434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Sontag, J. M.,
Fykse, E. M.,
Ushkaryov, Y.,
Liu, J. P.,
Robinson, P. J.,
and Südhof, T. C.
(1994)
J. Biol. Chem.
269,
4547-4554[Abstract/Free Full Text]
|
| 34.
|
Horisberger, M. A.,
McMaster, G. K.,
Zeller, H.,
Wathelet, M. G.,
Dellis, J.,
and Content, J.
(1990)
J. Virol.
64,
1171-1181[Abstract/Free Full Text]
|
| 35.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Ferrell, J. E.,
and Martin, G. S.
(1991)
Methods Enzymol.
200,
430-435[Medline]
[Order article via Infotrieve]
|
| 37.
|
Warnock, D. E.,
Terlecky, L. J.,
and Schmid, S. L.
(1995)
EMBO J.
14,
1322-1328[Medline]
[Order article via Infotrieve]
|
| 38.
|
Slepnev, V. I.,
Ochoa, G. C.,
Butler, M. H.,
Grabs, D.,
and De Camilli, P.
(1998)
Science
281,
821-824[Abstract/Free Full Text]
|
| 39.
|
Valtorta, F.,
Schiebler, W.,
Jahn, R.,
Ceccarelli, B.,
and Greengard, P.
(1986)
Anal. Biochem.
158,
130-137[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
McNiven, M. A.,
Cao, H.,
Pitts, K. R.,
and Yoon, Y.
(2000)
Trends Biochem. Sci.
25,
115-120[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Schmid, S. L.,
McNiven, M. A.,
and De Camilli, P.
(1998)
Curr. Opin. Cell Biol.
10,
504-512[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Ringstad, N.,
Nemoto, Y.,
and De Camilli, P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8569-8574[Abstract/Free Full Text]
|
| 43.
|
Gout, I.,
Dhand, R.,
Hiles, I. D.,
Fry, M. J.,
Panayotou, G.,
Das, P.,
Truong, O.,
Totty, N. F.,
Hsuan, J.,
Booker, G. W.,
Campbell, I. D.,
and Waterfield, M. D.
(1993)
Cell
75,
25-36[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Hinshaw, J. E.
(2000)
Annu. Rev. Cell Dev. Biol.
16,
483-519[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Hinshaw, J. E.,
and Schmid, S. L.
(1995)
Nature
374,
190-192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Takei, K.,
McPherson, P. S.,
Schmid, S. L.,
and De Camilli, P.
(1995)
Nature
374,
186-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Sweitzer, S. M.,
and Hinshaw, J. E.
(1998)
Cell
93,
1021-1029[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Marks, B.,
Stowell, M. H.,
Vallis, Y.,
Mills, I. G.,
Gibson, A.,
Hopkins, C. R.,
and McMahon, H. T.
(2001)
Nature
410,
231-235[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Sever, S.,
Muhlberg, A. B.,
and Schmid, S. L.
(1999)
Nature
398,
481-486[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
David, C.,
McPherson, P. S.,
Mundigl, O.,
and De Camilli, P.
(1996)
Proc. Natl. Acad. Sci. U. S. A. |